Astera Labs shares fall over 5% as sellers dominate after operational updates
Astera Labs (ALAB) slid 5.02% after sellers gained control following recent operational updates, even as the company posted strong revenue growth and product launches. The move is supported by persistent selling pressure below key moving averages and oversold technical signals.
Highlights
- Astera Labs reported second-quarter revenue of $392.4 million, a 104% increase from the prior year and introduced new products including Orion and Aries 7.
- Sax Wealth Advisors LLC initiated a position by acquiring 4,285 shares valued at approximately $1.52 million in the third quarter.
- Shares of Astera Labs last traded at $309.06, with short-term technicals indicating seller control and a projected five-day range of $269.28 to $348.84.
Revenue surge and new product launches as selling persists
Astera Labs reported second-quarter revenue of $392.4 million, a 104% year-over-year increase, and announced new products including the Orion architecture and Aries 7. Sax Wealth Advisors LLC initiated a new investment by acquiring 4,285 shares valued at approximately $1.52 million in the third quarter. The company also plans to demonstrate Orion at the Open Compute Project Global Summit and will release third-quarter results on November 3, 2026, though price action has remained under broader selling pressure.
Mixed technical signals as price holds above long-term support
Astera Labs is trading below its 20-day moving average ($345.08) and 50-day moving average ($317.81), indicating short- and medium-term pressure from sellers. The price remains above the 200-day moving average ($247.92), maintaining confirmation of a longer-term bullish structure. The near-term ceiling is set at $309.76, with support at $300.44. Momentum indicators are mixed; the MACD signals strong buy momentum, but the ADX suggests a neutral trend. The RSI and CCI both indicate selling pressure, and the Stochastic RSI is in extreme oversold territory. Bull/Bear Power (BBP) is negative at -18.08, showing sellers dominate intraday momentum and registering an oversold reading. The price is currently near the session low, with intraday volatility at 2.73%. Sellers have maintained control after the open, and oscillators amplify a cautious view despite the bullish MACD.
Earlier, analysts noted that Astera Labs faced persistent short-term selling pressure despite demonstrating strong fundamental growth and resilience in longer-term technical structure. The recent breakdown below additional key moving averages and continued dominance of sellers now raise the stakes around support at $300.44, with heightened volatility signaling that this is a crucial level to monitor for a potential escalation of downside risk.